BIOLINERX     Print Page  Close Window

SEC filings
SC 13G/A
ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP filed this Form SC 13G/A on 02/16/2016
Entire Document
 
 

 

CUSIP No.  09071M106
 SCHEDULE 13G/A
Page 4 of 8 Pages

 

Item 1.(a) Name of Issuer:

BioLineRx Ltd.

(b) Address of Issuer’s Principal Executive Offices:

2 HaMa’ayan Street

Modi’in 7177871, Israel

Item 2.(a) Name of Person Filing:

This Schedule 13G is being filed by each of the following persons (each, a “Reporting Person” and together, the “Reporting Persons”):

(i)  OrbiMed Israel BioFund GP Limited Partnership (“OrbiMed BioFund”); and

(ii) OrbiMed Israel GP Ltd. (“OrbiMed Israel”).

See Exhibit A for the Reporting Persons’ agreement for a joint filing of a single statement on their behalf.

(b) Address of Principal Business Office:

The address of the principal business office of each of OrbiMed BioFund and OrbiMed Israel is 89 Medinat HaYehudim St., Build E, 11th Floor, Herzliya 46766, Israel.

(c) Citizenship:

Each Reporting Person was organized under the laws of the State of Israel

 (d) Title of Class of Securities:

Ordinary Shares, NIS 0.01 par value (the “Ordinary Shares”)

 (e) CUSIP No.:

09071M106